1. Introduction {#sec1}
===============

Coordination chemistry is about tuning properties of metal ions using different ligands \[[@B1]--[@B3]\]. This includes stabilization of different oxidation states and modulation of the solvophilicity and electrophilic and nucleophilic properties of the metal ion \[[@B4]--[@B6]\]. While coordinating, the properties of the ligands themselves are also modified. For instance, the pharmacological activities and their crucial role in DNA/RNA base pairing through several hydrogen-bonding patterns of free oxypurines such as guanine can significantly change after complex formation \[[@B7], [@B8]\]. Based on this, synthesis of different coordination compounds with desired properties by ligand tailoring has become a fascinating research field. Designing new coordination compounds with therapeutic abilities has been part of this activity \[[@B9]--[@B17]\]. From this perspective, there has been a growing interest in the chemistry community to examine the biological activities of ruthenium complexes \[[@B18], [@B19]\]. Ruthenium (5*s* ^*2*^4*d* ^*6*^) frequently accesses +2 and +3 oxidation states at physiological conditions and can interact with nucleic acids, proteins, sulfur, or oxygen containing compounds and water in the cells \[[@B20]--[@B24]\]. Its interaction kinetics with the latter can be controlled using advantages of the unique properties of each kind of ligand. This enables the ligand exchange rates of ruthenium complexes to be close to those of cellular processes which make them suitable for therapeutic applications.

In this respect, numerous investigations in the properties and applications of ruthenium(II) complexes with 1,10-phenanthroline (phen) as a ligand or mixed with other ligands are reported \[[@B25]--[@B27]\]. Nevertheless, there is no report on the chemistry of ruthenium(III) complex containing 1,10-phenanthroline alone or 1,10-phenanthroline and guanide mixed.

The ideally placed nitrogen atoms along with their rigid planar structure and hydrophobic, electron-poor heteroaromatic, and *π*-acidic properties cooperatively made 1,10-phenanthroline a classic chelating bidentate ligand. These properties enable it to have stacking interaction ability with DNA base pairs \[[@B28]--[@B31]\]. Guanine is a chemically inert oxypurine heteroaromatic molecule. Its inertness is changed by complex formation. The latter is favored in its guanide (G^−^) form which is derived by deprotonation of guanine.

The purpose of this study is to examine the effects of 1,10-phenanthroline alone and mixed with guanide on the biological activity of Ru(III). The complex would orchestrate the binding ability of ruthenium with a range of biomolecules, the unique stacking interaction ability of 1,10-phenanthroline on cell genetic material, and the interaction of guanide through hydrogen bonding with cytosine residue of the genetic material.

2. Experimental {#sec2}
===============

2.1. Chemicals {#sec2.1}
--------------

All chemicals used in the present work are as follows: 1,10-phenanthroline monohydrate (BDH Chemical Ltd., Poole, England), guanine (99%, ACROS), RuCl~3~, silver nitrate, sodium hydroxide, acetone, chloroform, sulfuric acid (Sigma Aldrich), methanol (Hi Media Laboratories Ltd., India), KBr, dichloromethane, Mueller Hinton agar, and barium chloride (BLULUX Laboratories Ltd., India), and nitric acid (T.V. Industrial Estate, India).

2.2. Instruments and Methods {#sec2.2}
----------------------------

The electronic conductance was measured using 10^−3 ^M solution of each complex in deionized water with JENWAY 4200 conductivity meter at room temperature. The electronic spectra were recorded in the 200--800 nm region on Sanyo SP65 UV/Vis spectrophotometer. IR spectra were recorded using KBr discs in the 4000--400 cm^−1^ region on AVATAR 330 FTIR, Thermo Nicolet spectrophotometer. Ruthenium content was determined by PerkinElmer, Optima 7300 V HF Version ICP-OES spectrometer, digesting 10 mg of each complex in concentrated nitric acid and diluting them using distilled water. Melting points were determined using STONE, STAFFORDSHIRE, ST15 OSA, UK, digital melting point apparatus. Chloride ions were determined thermogravimetrically using the AgCl precipitate obtained from the mixture of 10 mL solution of 1 mg of each complex in distilled water with excess AgNO~3~ solution.

2.3. Synthesis {#sec2.3}
--------------

### 2.3.1. Synthesis of \[Ru(Phen)~2~(Cl)~2~\]Cl·2H~2~O {#sec2.3.1}

Ethanolic solution of 1,10-phenanthroline (1 g, 5 mmol) was added from a dropping funnel to an ethanolic solution of RuCl~3~ (0.5 g, 2.5 mmol) being stirred magnetically in an ice bath. The mixture was allowed to stir for 3 h at room temperature. Reddish-brown homogeneous solution was obtained. The solvent was removed in vacuum. Reddish-brown powder was collected and washed three times with acetone to remove any unreacted 1,10-phenanthroline. It was recrystallized from ethanol to remove any unreacted RuCl~3~ (yield: 1.2 g, 80%).

### 2.3.2. Synthesis of \[Ru(Phen)~2~(G)(Cl)\]Cl·H~2~O {#sec2.3.2}

An aqueous solution of sodium guanide obtained from a reaction between guanine (0.125 g, 8.0 mmol) and sodium hydroxide (0.032 g, 8.0 mmol) was added from a dropping funnel to an aqueous solution of \[Ru(Phen)~2~(Cl)~2~\]Cl·2H~2~O (0.5 g, 8.0 mmol) while stirring in an oil bath at 80°C. The mixture was allowed to stir for 3 h. The resulting orange-red homogeneous solution was mixed with 100 mL dichloromethane and stirred for 1 h and allowed to stand overnight. The organic (dichloromethane) phase was separated using separatory funnel. The dichloromethane was removed in vacuum and dark brown powder was collected and recrystallized from ethanol (yield: 0.546 g, 87%). The reaction paths of the two synthetic complexes are shown in [Scheme 1](#sch1){ref-type="fig"}.

2.4. Antibacterial Activity Testing {#sec2.4}
-----------------------------------

The ligands and their metal complexes were evaluated for in vitro antibacterial activities against strains of two Gram-positive (*S. aureus* (ATCC 25923) and methicillin resistant*S. aureus* (clinical isolate)) and two Gram-negative (*E. coli* (ATCC255922) and*K. pneumoniae* (ATCC986605)) bacteria. The bacterial strains were maintained in the appropriate blood agar base at 4°C. Antibiotic discs (Ciprofloxacin 5 *μ*g and Chloramphenicol 30 *μ*g) were used as reference. The minimum inhibitory concentration (MIC) against each bacterium was determined by preparing aqueous solutions of different concentrations of the complexes by serial dilution (200 *μ*g/mL, 300 *μ*g/mL, 400 *μ*g/mL, 500 *μ*g/mL, 600 *μ*g/mL, 800 *μ*g/mL, and 1000 *μ*g/mL). The experiments were repeated three times to obtain consistent results. The antibacterial tests were carried out at the Amhara Regional Health Research Microbiology Laboratory Center, Bahir Dar, Ethiopia.

3. Results and Discussion {#sec3}
=========================

The analytical data of the complexes are indicated in [Table 1](#tab1){ref-type="table"}.

3.1. Molar Conductance of the Metal Complexes {#sec3.1}
---------------------------------------------

The conductance measurements, recorded for 10^−3 ^M solutions of the metal complexes in deionized water, are listed in [Table 1](#tab1){ref-type="table"}. The data shows that both complexes are 1 : 1 electrolytes \[[@B32]\]. The lower conductance of \[Ru(phen)~2~(G)(Cl)\]Cl·H~2~O compared to \[Ru(phen)~2~Cl~2~\]Cl·2H~2~O is a consequence of increase in molar mass and the surface area. Hence the speed of mobility of the cation decreases as a result of the decrease in the kinetic energy imparted by the electric field from measurement instrument \[[@B33]\].

3.2. Electronic Spectra {#sec3.2}
-----------------------

The electronic spectra of the complexes are displayed in [Figure 1](#fig1){ref-type="fig"} and [Table 2](#tab2){ref-type="table"}.

The complexes exhibited simple characteristic d-d transitions. The difference in the band position for d-d transition absorption of RuCl~3~ and the complexes may be explained by assuming different environments around the metal ion following the coordination \[[@B34], [@B35]\]. The coordination of 1,10-phenanthroline to Ru(III) results in a distorted octahedral geometry. Consequently, the *e* ~g~ orbitals split to d~*z*2~ and d~*x*2-*y*2~ resulting in two transitions (t~2g~ → *e* ~g~(d~*z*2~) and t~2g~ → *e* ~g~(d~*x*2-*y*2~)). \[Ru(Phen)~2~(G)(Cl)\]Cl·H~2~O demonstrated absorption at longer wavelength ([Figure 1(c)](#fig1){ref-type="fig"}) than \[Ru(Phen)~2~(Cl)~2~\]Cl·2H~2~O ([Figure 1(b)](#fig1){ref-type="fig"}). This is probably because guanide (G^−^) formed a shorter and stronger bond that narrowed the transition (t~2g~ → *e* ~g~) gap ([Figure 1](#fig1){ref-type="fig"} and [Table 2](#tab2){ref-type="table"}).

3.3. IR Spectroscopy {#sec3.3}
--------------------

The infrared spectra of the ligands and the complexes are indicated in [Figure 2](#fig2){ref-type="fig"} and selected characteristic frequencies are indicated in [Table 3](#tab3){ref-type="table"}.

The bands at 1623 cm^−1^ (s) and 1587 cm^−1^ (s), characteristic for *ν* ~C=C~ and *ν* ~C=N~ stretching in the free 1,10-phenanthroline monohydrate ([Figure 2(a)](#fig2){ref-type="fig"}), appear at 1670 cm^−1^ (w) and 1429 cm^−1^ (w), respectively, in \[Ru(phen)~2~(G)(Cl)\]Cl·H~2~O ([Figure 2(d)](#fig2){ref-type="fig"}). They also appeared at 1633 cm^−1^ (w) and 1540 cm^−1^ (w), respectively, in \[Ru(phen)~2~(Cl)~2~\]Cl·2H~2~O ([Figure 2(c)](#fig2){ref-type="fig"}). Similarly, the characteristic bands of guanide at 3335 cm^−1^ (s), 3112 cm^−1^ (s) *ν* ~N-H~(NH~2~), and 1710 cm^−1^ (s) (*ν* ~C=O~) ([Figure 2(b)](#fig2){ref-type="fig"}) are displaced towards 3340 cm^−1^ (w) and 1697 cm^−1^ (w) ([Figure 2(d)](#fig2){ref-type="fig"}), respectively. The changes in absorption frequencies and strength suggest that 1,10-phenanthroline and guanide are coordinated. The strong and broad bands at 3439 cm^−1^ and 3416 cm^−1^ characteristic for *ν* ~O-H~(H~2~O) in the free 1,10-phenanthroline monohydrate and \[Ru(phen)~2~(Cl)~2~\]Cl·2H~2~O, respectively (Figures [2(a)](#fig2){ref-type="fig"} and [2(b)](#fig2){ref-type="fig"}), appear at 3431 cm^−1^ obscured in the band characteristic for *ν* ~N-H~(NH~2~) in \[Ru(phen)~2~(G)(Cl)\]Cl·H~2~O ([Figure 2(d)](#fig2){ref-type="fig"}). This change in the absorption frequency of water explains the change in the nature of its interaction. Moreover, the change in the intensity may explain the change in the relative amount of water molecules in 1,10-phenanthroline monohydrate and the complexes. The latter argument supports the proposed formula of the complexes.

3.4. Antibacterial Activity Testing {#sec3.4}
-----------------------------------

This observation shows that the complexes demonstrated biological activities against all the tested strains ([Figure 3](#fig3){ref-type="fig"} and [Table 4](#tab4){ref-type="table"}). The observed increase in antibacterial activity can be explained on the basis of Overtone\'s concept \[[@B36]\] and Tweedy\'s chelation theory \[[@B37]\]. The lipid membrane that surrounds the cell favors the passage of only lipid soluble materials which is an important condition for antimicrobial activity. On coordination, the polarity of the metal ion will be reduced to a greater extent due to the overlap of the ligand orbitals and partial sharing of the positive charge of the metal ion with the donor groups. Further, it increases the delocalization of *π* electrons over the whole chelate ring and hence enhances the liposolubility of the complexes. This increased liposolubility enhances the penetration of the complexes into the lipid membrane and interferes in the normal activities of the bacteria \[[@B38]\].

The percent activity indexes of the complexes against the reference antibiotics demonstrated significant comparative inhibitions ([Table 5](#tab5){ref-type="table"}). \[Ru(phen)~2~(G)(Cl)\]Cl·H~2~O showed better activity than the two commercial antibiotics (Ciprofloxacin and Chloramphenicol) against all the strains studied including the most drug resistant Gram-negative*K*.*pneumoniae*. \[Ru(phen)~2~(Cl)~2~\]Cl·2H~2~O also showed nearly equal activities as Chloramphenicol against*S. aureus* and*E. coli* and better activities against MARSA and*K*.*pneumoniae* ([Table 5](#tab5){ref-type="table"}). The better activities demonstrated by \[Ru(phen)~2~(G)(Cl)\]Cl·H~2~O compared to \[Ru(phen)~2~(Cl)~2~\]Cl·2H~2~O are due to its additional interaction with the genetic material of the cell by guanide.

3.5. Minimum Inhibitory Concentration (MIC) Determination {#sec3.5}
---------------------------------------------------------

MIC is the lowest concentration that completely inhibited the growth of microorganisms for 24 hours.

Around 300 *μ*g/mL \[Ru(Phen)~2~(G)(Cl)\]Cl·H~2~O is sufficient to inhibit the growth of*E. coli* while around 400 *μ*g/mL is necessary to start inhibiting*S. aureus* and*K. pneumonia* ([Table 6](#tab6){ref-type="table"}).

4. Conclusions {#sec4}
==============

In this synthesis, Ru(III) and the ligands are brought together with rigid configuration. This resulted in delocalization of *π* electrons over the whole cationic unit and hence the reduction of the polarity of the complexes which increased the liposolubility. This has enhanced the penetration of the complexes into the lipid membrane and inhibited the growth of the tested Gram-positive and Gram-negative bacteria. The latter phenomenon demonstrates the wide-range activities of the complexes.
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###### 

Analytical data of the complexes.

  -------------------------------------------------------------------------------------------------------------------------------------------
  Complex (color)                                   Melting point/°C   Yield (%)   Elemental estimation\    Molar conductivity\      
                                                                                   Calculated (found) (%)   Λ~M~ (S cm^2^ mol^−1^)   
  ------------------------------------------------- ------------------ ----------- ------------------------ ------------------------ --------
  \[Ru(phen)~2~(Cl)~2~\]Cl·2H~2~O (reddish brown)   \>300              80          16.74 (16.62)            5.88 (5.66)              121.50

  \[Ru(phen)~2~(G)(Cl)\]Cl·H~2~O (orange red)       \>300              87          14.47 (14.23)            5.07 (4.89)              87.26
  -------------------------------------------------------------------------------------------------------------------------------------------

###### 

Electronic spectral data of the salt and complexes.

  Complex                           Band position (nm)   Assignment
  --------------------------------- -------------------- -------------------------------------
  RuCl~3~                           295, 573             ^*∗*^LMCT, d-d(^2^T~2g~ → ^2^T~1g~)
  \[Ru(phen)~2~(Cl)~2~\]Cl·2H~2~O   643                  d-d(^2^T~2g~ → ^2^T~1g~)
  \[Ru(phen)~2~(G)(Cl)\]Cl·H~2~O    657                  d-d(^2^T~2g~ → ^2^T~1g~)

^*∗*^LMCT: ligand to metal charge transfer.

###### 

Important characteristic IR bands of the ligands and complexes, cm^−1^.

  Compound                           Absorption frequencies, cm^−1^                                                                
  --------------------------------- --------------------------------- ---------------- ---------- ---------- ---------- ---------- ----------
  1,10-Phenanthroline monohydrate   3439 (s, b)                       ---              3045 (w)   1290 (w)   1623 (s)   1587 (s)   ---
  Guanine                           ---                               3335, 3112 (d)   2992       1256 (w)   1692       1563 (w)   1710 (s)
  \[Ru(Phen)~2~(Cl)~2~\]Cl·2H~2~O   3416 (s, b)                       ---              2925 (w)   1208 (w)   1633 (w)   1540 (w)   ---
  \[Ru(Phen)~2~(G)(Cl)\]Cl·H~2~O    3431                              3340 (s)         2912 (w)   1270       1670       1429       1697

s: strong, b: broad, w: weak, and d: doublet.

###### 

Antibacterial activities of the complexes, free ligands, metal salt, and commercially available antibiotics.

  Compound                           Inhibition zone (mm)                                
  --------------------------------- ----------------------- ------------- -------------- --------------
  1,10-Phenanthroline               27.40 ± 0.12            26.4 ± 0.11   28.20 ± 0.12   26.00 ± 0.14
  Guanine                           ---                     ---           ---            ---
  RuCl~3~                           ---                     ---           12.20 ± 0.21   ---
  \[Ru(Phen)~2~(Cl)~2~\]Cl·2H~2~O   25.54 ± 0.15            24.56 ± 0.2   26.53 ± 0.13   26.50 ± 0.13
  \[Ru(Phen)~2~(G)(Cl)\]Cl·H~2~O    29.65 ± 0.13            28.8 ± 0.21   30.70 ± 0.11   30.70 ± 0.11
  Ciprofloxacin                     28.00 ± 0.14            27.4 ± 0.13   30.00 ± 0.10   26.20 ± 0.32
  Chloramphenicol                   25.24 ± 0.14            22.6 ± 0.15   26.50 ± 0.23   20.20 ± 0.35

###### 

The % activity index data of the complexes against the tested bacteria compared to (a) Chloramphenicol and (b) Ciprofloxacin.

  Microorganism                                               
  -------------------------------- -------- -------- -------- --------
  \[Ru(Phen)~2~(Cl)~2~\]Cl·H~2~O   11.00%   8.70%    0.10%    31.20%
  \[Ru(Phen)~2~(G)(Cl)\]Cl·H~2~O   17.50%   27.40%   15.85%   52.00%

  Microorganism                                                  
  --------------------------------- -------- --------- --------- --------
  \[Ru(Phen)~2~(Cl)~2~\]Cl·2H~2~O   −8.80%   −10.00%   −12.00%   1.01%
  \[Ru(Phen)~2~(G)(Cl)\]Cl·H~2~O    5.90%    5.10%     2.30%     17.17%

MRSA: methicillin resistant *S*. *aureus*.

###### 

MIC assay of \[Ru(Phen)~2~(G)(Cl)\]Cl~2~·H~2~O against four bacterial pathogens.

  Microorganism     Minimum concentration of microorganism growth                                           
  ----------------- ----------------------------------------------- ------- ------- ------- ------- ------- -------
  *S. aureus*       **+**                                           **+**   **−**   **−**   **−**   **−**   **−**
  MRSA              **+**                                           **+**   **+**   **+**   **−**   **−**   **−**
  *K. pneumoniae*   **+**                                           **+**   **−**   **−**   **−**   **−**   **−**
  *E. coli*         **+**                                           **−**   **−**   **−**   **−**   **−**   **−**

Note: +: bacteria growth and −: no bacteria growth.
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